Silvia Mijares-Landin, OD
Optometrist · Las Vegas, NVNPI 1679131700
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,759 of the $5,221 with a category attached, or 72.0%. 15 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 31.2% of the total. Among optometrist clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $76.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- Alcon$1K
- Bausch & Lomb Americas Inc.$542
- Sun Pharmaceutical Industries Inc.$377
- AbbVie$278
- Coopervision Inc.$273
- plus $952 from 9 others
What the payments were for
- Travel & lodging$1,46228%
- Food & beverage$3,75972%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 16 | $1,629 |
| Alcon | 18 | $1,169 |
| Bausch & Lomb Americas Inc. | 8 | $542 |
| Sun Pharmaceutical Industries Inc. | 3 | $377 |
| AbbVie(2 entities) | 4 | $278 |
| Coopervision Inc. | 4 | $273 |
| Tarsus Pharmaceuticals, Inc. | 6 | $264 |
| Shire North American Group Inc | 1 | $122 |
| Biotissue Holdings Inc. | 1 | $121 |
| Kala Pharmaceuticals, Inc. | 1 | $114 |
| Rxsight Inc | 1 | $104 |
| Ivantis, Inc | 1 | $98 |
| Johnson & Johnson Vision Care, Inc. | 2 | $90 |
| Carl Zeiss Meditec USA, Inc. | 1 | $21 |
| Oyster Point Pharma, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MULTI-FOCAL LENS$1,133
- ULTRA$1,023
- BIOTRUE ONE DAY$1,023
- ZEN LENS$1,023
- XIIDRA$479
- CEQUA$252
- Precision7$237
- MIEBO$234
- BROMSITE$125
- LOTEMAX SM$121
- VUITY$120
- XDEMVY$117
- EYSUVIS$114
- LUMIGAN$114
- RXSIGHT CONTACT LENS$104
- RXSIGHT INJECTOR HANDPIECE$104
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$104
- RXSIGHT INJECTOR CARTRIDGE$104
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$104
How this compares
$5,221 in reported general payments places this provider in the 90th percentile of 494 optometrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 19 | $640 |
| ErythromycinErythromycin Base | 17 | $199 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Las Vegas
- Eric BrookerLas Vegas$53K
- My VuongLas Vegas$47K
- Chen YoungLas Vegas$46K
- Harlan KopolowLas Vegas$36K
- Jenny WongLas Vegas$34K
- Adam SchwartzLas Vegas$26K
- Lawrence WangLas Vegas$12K
- Brian MillerLas Vegas$11K
- Mark MillerLas Vegas$8K
- Victoria MarLas Vegas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.